PubRank

A Giwercman

Author PubWeight™ 148.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evidence for decreasing quality of semen during past 50 years. BMJ 1992 17.44
2 Pathogenesis and management of male infertility. Lancet 1994 5.31
3 Male reproductive health and environmental xenoestrogens. Environ Health Perspect 1996 4.11
4 Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet 1998 3.34
5 The predictive value of sperm chromatin structure assay (SCSA) parameters for the outcome of intrauterine insemination, IVF and ICSI. Hum Reprod 2004 3.24
6 Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 1987 2.61
7 Sperm DNA integrity assessment in prediction of assisted reproduction technology outcome. Hum Reprod 2006 2.36
8 Late-onset hypogonadism and mortality in aging men. J Clin Endocrinol Metab 2013 1.77
9 Sperm chromatin structure and male fertility: biological and clinical aspects. Asian J Androl 2006 1.71
10 Chronic widespread pain is associated with slower cognitive processing speed in middle-aged and older European men. Pain 2010 1.58
11 Does moderate alcohol consumption affect fertility? Follow up study among couples planning first pregnancy. BMJ 1998 1.57
12 Spontaneous abortion and physical strain around implantation: a follow-up study of first-pregnancy planners. Epidemiology 2000 1.54
13 Change in semen quality and sperm chromatin structure following occupational styrene exposure. ASCLEPIOS. Int Arch Occup Environ Health 1999 1.50
14 Germ cell cancer and disorders of spermatogenesis: an environmental connection? APMIS 1998 1.47
15 A follow-up study of environmental and biologic determinants of fertility among 430 Danish first-pregnancy planners: design and methods. Reprod Toxicol 1998 1.46
16 Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol 2012 1.44
17 Insulin-like growth factor-I in celiac disease. J Pediatr Gastroenterol Nutr 1994 1.38
18 The applicability of the flow cytometric sperm chromatin structure assay in epidemiological studies. Asclepios. Hum Reprod 1998 1.36
19 Semen analysis performed by different laboratory teams: an intervariation study. Int J Androl 1997 1.30
20 Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. J Clin Endocrinol Metab 1997 1.30
21 Intra-individual variation in sperm chromatin structure assay parameters in men from infertile couples: clinical implications. Hum Reprod 2006 1.29
22 Prevalence of high DNA fragmentation index in male partners of unexplained infertile couples. Andrology 2012 1.28
23 Identifying environmental risk to male reproductive function by occupational sperm studies: logistics and design options. Occup Environ Med 1996 1.28
24 Computer-assisted semen analysis parameters as predictors for fertility of men from the general population. The Danish First Pregnancy Planner Study Team. Hum Reprod 2000 1.26
25 Intra-individual variation of the sperm chromatin structure assay DNA fragmentation index in men from infertile couples. Hum Reprod 2011 1.25
26 Exposure to CB-153 and p,p'-DDE and male reproductive function. Hum Reprod 2004 1.24
27 Caffeine intake and fecundability: a follow-up study among 430 Danish couples planning their first pregnancy. Reprod Toxicol 1998 1.19
28 Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol 2013 1.17
29 Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Lab Invest 1995 1.17
30 [European Association of Urology guidelines on vasectomy]. Actas Urol Esp 2012 1.13
31 Gonadal function in men with testicular cancer. Semin Oncol 1998 1.12
32 Declining semen quality and increasing incidence of testicular cancer: is there a common cause? Environ Health Perspect 1995 1.10
33 Testicular cancer after vasectomy: origin from carcinoma in situ of the testis. Eur J Cancer 1993 1.10
34 The human testis--an organ at risk? Int J Androl 1992 1.08
35 The impact of epididymal and accessory sex gland function on sperm motility. Hum Reprod 2002 1.07
36 Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours. Int J Cancer 1996 1.05
37 Radiation treatment of carcinoma-in-situ of testis. Lancet 1986 1.04
38 Semen quality and sex hormones with reference to metal welding. Reprod Toxicol 1998 1.03
39 Exposure to perfluorinated compounds and human semen quality in Arctic and European populations. Hum Reprod 2012 1.03
40 Adult and prenatal exposures to tobacco smoke as risk indicators of fertility among 430 Danish couples. Am J Epidemiol 1998 1.03
41 No secular trend over the last decade in sperm counts among Swedish men from the general population. Hum Reprod 2011 1.01
42 Semen quality among members of organic food associations in Zealand, Denmark. Lancet 1996 1.00
43 Management of carcinoma-in-situ of the testis. Int J Androl 1987 0.99
44 Distress and reduced fertility: a follow-up study of first-pregnancy planners. Fertil Steril 1999 0.99
45 Endocrine and reproductive health status of men who had experienced short-term radiation exposure at Chernobyl. Int J Androl 1998 0.99
46 Ultrasonic testicular texture and size in 444 men from the general population: correlation to semen quality. Eur Urol 1993 0.98
47 Menstrual cycle pattern and fertility: a prospective follow-up study of pregnancy and early embryonal loss in 295 couples who were planning their first pregnancy. Fertil Steril 1999 0.98
48 Sperm count and chromatin structure in men exposed to inorganic lead: lowest adverse effect levels. Occup Environ Med 2002 0.98
49 Serum bone Gla-protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor I, and serum testosterone. J Clin Endocrinol Metab 1988 0.97
50 Carcinoma-in-situ germ-cells exfoliated from seminiferous epithelium into seminal fluid. Lancet 1988 0.97
51 Effect of repeated ejaculation on semen quality in spinal cord injured men. J Urol 1999 0.97
52 Higher sperm counts in Southern Sweden compared with Denmark. Hum Reprod 2002 0.95
53 Sperm DNA integrity in testicular cancer patients. Hum Reprod 2006 0.95
54 Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA. Int J Androl 2008 0.95
55 Investigation of the criteria for assessing the outcome of treatment in acromegaly. Clin Endocrinol (Oxf) 1987 0.94
56 Gonadal function in men with testicular cancer: biological and clinical aspects. APMIS 1998 0.94
57 Influence of age and sex steroids on bone density and geometry in middle-aged and elderly European men. Osteoporos Int 2010 0.94
58 CAG repeat number is not inversely associated with androgen receptor activity in vitro. Mol Hum Reprod 2009 0.93
59 Semen quality and reproductive hormones before orchiectomy in men with testicular cancer. J Clin Oncol 1999 0.93
60 Fecundability according to male serum inhibin B--a prospective study among first pregnancy planners. Hum Reprod 2005 0.93
61 Investigating the determinants of international differences in the prevalence of chronic widespread pain: evidence from the European Male Ageing Study. Ann Rheum Dis 2008 0.93
62 Ultrasound in detection of early neoplasia of the testis. Int J Androl 1987 0.92
63 Functional in vitro characterisation of the androgen receptor GGN polymorphism. Mol Cell Endocrinol 2006 0.91
64 CHEK2*1100delC is not an important high-risk gene in families with hereditary prostate cancer in southern Sweden. Scand J Urol Nephrol 2006 0.91
65 Craniofacial morphology in patients with Kallmann's syndrome with and without cleft lip and palate. Cleft Palate Craniofac J 1997 0.89
66 Relationships between sperm DNA fragmentation, sperm apoptotic markers and serum levels of CB-153 and p,p'-DDE in European and Inuit populations. Reproduction 2006 0.89
67 Inter-observer variation in the results of the clinical andrological examination including estimation of testicular size. Int J Androl 2000 0.89
68 Secular and seasonal changes in semen quality among young Danish men: a statistical analysis of semen samples from 1927 donor candidates during 1977-1995. Int J Androl 1999 0.88
69 Sperm DNA integrity in cancer patients: the effect of disease and treatment. Int J Androl 2008 0.88
70 Human semen quality in relation to dietary pesticide exposure and organic diet. Arch Environ Contam Toxicol 1999 0.88
71 Non-linear association between androgen receptor CAG repeat length and risk of male subfertility--a meta-analysis. Int J Androl 2010 0.88
72 High risk of azoospermia in men treated for childhood cancer. Int J Androl 2011 0.87
73 Semen quality and sex hormones among organic and traditional Danish farmers. ASCLEPIOS Study Group. Occup Environ Med 1999 0.87
74 A longitudinal study of semen quality in pesticide spraying Danish farmers. The ASCLEPIOS Study Group. Reprod Toxicol 1999 0.87
75 Toluidine blue cytometry test for sperm DNA conformation: comparison with the flow cytometric sperm chromatin structure and TUNEL assays. Hum Reprod 2004 0.87
76 Menstrual cycle characteristics in European and Inuit women exposed to persistent organochlorine pollutants. Hum Reprod 2007 0.86
77 Year of birth and sperm count in 10 Danish occupational studies. Scand J Work Environ Health 1998 0.85
78 Changes in the profile of simple mucin-type O-glycans and polypeptide GalNAc-transferases in human testis and testicular neoplasms are associated with germ cell maturation and tumour differentiation. Virchows Arch 2007 0.85
79 Testicular biopsy as an outpatient procedure in screening for carcinoma-in-situ: complications and the patient's acceptance. Int J Androl 1987 0.85
80 A follow-up study of male exposure to welding and time to pregnancy. Reprod Toxicol 1998 0.85
81 Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer. Ann Oncol 1994 0.84
82 DNA content and expression of tumour markers in germ cells adjacent to germ cell tumours in childhood: probably a different origin for infantile and adolescent germ cell tumours. J Pathol 1995 0.84
83 Falling sperm quality. BMJ 1994 0.84
84 A novel maturation marker for human Sertoli cells. Int J Androl 1989 0.83
85 Clinical and biological significance of carcinoma in situ of the testis. Cancer Surv 1990 0.83
86 The impact of testicular and accessory sex gland function on sperm chromatin integrity as assessed by the sperm chromatin structure assay (SCSA). Hum Reprod 2002 0.83
87 Fluorescence in situ hybridization analysis of chromosome 12 anomalies in semen cells from patients with carcinoma in situ of the testis. J Pathol 1998 0.83
88 Impaired testicular function in patients with carcinoma-in-situ of the testis. J Clin Oncol 1999 0.82
89 Polymorphisms, haplotypes and mutations in the protamine 1 and 2 genes. Int J Androl 2010 0.81
90 Gonadal sex steroid status and bone health in middle-aged and elderly European men. Osteoporos Int 2009 0.81
91 Visco-elasticity of seminal fluid in relation to the epididymal and accessory sex gland function and its impact on sperm motility. Int J Androl 2004 0.81
92 Immunohistochemical markers of carcinoma in situ of the testis also expressed in normal infantile germ cells. Histopathology 1993 0.81
93 Stereological methods as efficient and unbiased tools to quantitate structures in the testis. Scand J Work Environ Health 1999 0.81
94 Male-mediated spontaneous abortion among spouses of stainless steel welders. Scand J Work Environ Health 2000 0.81
95 Screening for carcinoma-in-situ of the testis. Int J Androl 1987 0.81
96 Decreasing quality of semen. BMJ 1993 0.81
97 Androgen receptor gene GGN repeat length and reproductive characteristics in young Swedish men. Eur J Endocrinol 2006 0.81
98 High prevalence of androgen deficiency and abnormal lipid profile in infertile men with non-obstructive azoospermia. Int J Androl 2012 0.80
99 Flow cytometric sperm chromatin structure assay as an independent descriptor of human semen quality. Scand J Work Environ Health 1999 0.80
100 Impact of therapy and androgen receptor polymorphism on sperm concentration in men treated for testicular germ cell cancer: a longitudinal study. Hum Reprod 2004 0.80
101 Exposure to persistent organochlorine pollutants and seminal levels of markers of epididymal and accessory sex gland functions in Swedish men. Hum Reprod 2005 0.79
102 Semen quality and reproductive hormones before and after orchiectomy in men with testicular cancer. J Urol 1999 0.79
103 Thyroid hormones and male sexual function. Int J Androl 2012 0.79
104 Detection and enrichment of carcinoma-in-situ cells in semen by an immunomagnetic method using monoclonal antibody M2A. Int J Androl 1996 0.79
105 Objectives, designs and populations of the European Asclepios study on occupational hazards to male reproductive capability. Scand J Work Environ Health 1999 0.79
106 No association between mutations in the human androgen receptor GGN repeat and inter-sex conditions. Mol Hum Reprod 2003 0.79
107 Frailty Is Associated with Impaired Quality of Life and Falls in Middle-Aged and Older European Men. J Frailty Aging 2013 0.78
108 Modifying effect of the AR gene trinucleotide repeats and SNPs in the AHR and AHRR genes on the association between persistent organohalogen pollutant exposure and human sperm Y:X ratio. Mol Hum Reprod 2007 0.78
109 Significant impact of 5alpha-reductase type 2 polymorphisms on sperm concentration and motility. Int J Androl 2006 0.78
110 Non-linear association between androgen receptor CAG and GGN repeat lengths and reproductive parameters in fertile European and Inuit men. Mol Cell Endocrinol 2013 0.78
111 Spermatozoa DNA damage measured by sperm chromatin structure assay (SCSA) and birth characteristics in children conceived by IVF and ICSI. Int J Androl 2011 0.78
112 Sperm chromatin structure and semen quality following occupational styrene exposure. Asclepios. Scand J Work Environ Health 1999 0.78
113 Neuropeptide Y in the human prenatal and mature gonads. Neuropeptides 1996 0.78
114 Evaluation of male fertility potential by Toluidine Blue test for sperm chromatin structure assessment. Hum Reprod 2009 0.78
115 Incidence of testicular mononuclear cell infiltrates in normal human males and in patients with germ cell neoplasia. Int J Androl 1995 0.77
116 Should the other testis be biopsied? Semin Urol Oncol 1996 0.77
117 Job strain and time to pregnancy. Scand J Work Environ Health 1998 0.77
118 International Society of Andrology and International Union of Pure and Applied Chemistry, Clinical Chemistry Section, Commission on Nomenclature, and International Federation of Clinical Chemistry Scientific Division. Properties and units in the clinical laboratory sciences XIII. Properties and units in reproduction and fertility (IUPAC-IFCC technical report 1998). Clin Chim Acta 1998 0.77
119 Seminal characteristics following exposure to pesticides among agricultural workers. Asclepios. Scand J Work Environ Health 1999 0.77
120 Epidemiological evidence against a role for C-reactive protein causing leptin resistance. Eur J Endocrinol 2012 0.76
121 The effect of salicylazosulphapyridine (sulphasalazine) on male fertility. A review. Int J Androl 1986 0.76
122 Semen quality in testicular tumour and CIS in the contralateral testis. Lancet 1993 0.75
123 The impact of androgen receptor polymorphism and parental ethnicity on semen quality in young men from Latvia. Int J Androl 2007 0.75
124 Ultrasound scanning in the field of andrology. J Androl 2001 0.75
125 Hormones and growth factors in germ cell neoplasia: general discussion. Eur Urol 1993 0.75
126 [Testicular carcinoma in situ]. Ugeskr Laeger 1988 0.75
127 Ring Y chromosome in an azoospermic male with short stature: additional evidence for a distinct ring Y syndrome in non-mosaic patients? Clin Genet 2003 0.75
128 Properties and units in the clinical laboratory sciences. XIII. Properties and units in reproduction and fertility. International Society of Andrology (ISA). International Union of Pure and Applied Chemistry. International Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med 1998 0.75
129 DNA distributions in maldescended testes: hyperdiploid aneuploidy without evidence of germ cell neoplasia. Cytometry 1991 0.75
130 Investigation of carcinoma in situ cells of testis by quantification of argyrophilic nucleolar organizer region associated proteins (AgNORs). J Pathol 1996 0.75
131 Quality of semen obtained by penile vibratory stimulation in men with spinal cord injuries: observations and predictors. Urology 1996 0.75
132 Declining sperm counts and increasing incidence of testicular cancer and other gonadal disorders: is there a connection? Ir Med J 1993 0.75
133 Insulin-like growth factor I (somatomedin C) in goats during normal lactation and in response to somatotropin treatment. Comp Biochem Physiol A Comp Physiol 1990 0.75
134 Magnetic resonance: in vivo tissue characterization of the testes in patients with carcinoma-in-situ of the testis and healthy subjects. Int J Androl 1987 0.75
135 [Age- and sex-related variations in the serum concentration of somatomedin C in normal children and adults]. Ugeskr Laeger 1987 0.75
136 Carcinoma in situ of the testis. Acta Urol Belg 1985 0.75
137 Selection biases in semen study? Fertil Steril 1998 0.75
138 Ultrasonic texture and volume of testicles in infertile men. Hum Reprod 1994 0.75
139 Training in andrology: the level 1 programme of the European Academy of Andrology (EAA) and of the European Society for Andrological Urology (ESAU). Int J Androl 2007 0.75
140 Epidemiologic evidence on biological and environmental male factors in embryonic loss. Adv Exp Med Biol 2003 0.75
141 Monoclonal antibody 43-9F: an immunohistochemical marker of embryonal carcinoma of the testis. APMIS 1992 0.75
142 Carcinoma-in-situ of the cryptorchid testis. Prog Clin Biol Res 1985 0.75
143 Inhibin B concentration is predictive for long-term azoospermia in men treated for testicular cancer. Andrology 2014 0.75